Skip to main content
. 2007 Feb 28;75(2):121–128. doi: 10.1016/j.antiviral.2007.01.158

Table 2.

Effect of the administration of IFN-alphaA initiated 24 h before mice infection (i.p.) with distinct Orthobunyavirus

Viruses Survived/total (percent survival)
MTDa ± S.D. (days)
Placebo IFN-αA Placebo IFN-αA
OROV 0/16 16/16 (100%)b 8.5 ± 3.5 >20
CARV 2/16 (12%) 6/16 (37%) 8.0 ± 2.8 9.0 ± 2.8
GMAV 0/16 0/16 6.0 ± 0 9.5 ± 3.5
GROV 0/16 16/16 (100%)b 6.0 ± 0 >20
TCMV 0/16 0/16 6.5 ± 3.5 10.0 ± 2.8
a

Mean time to death.

b

p < 0.001; Fisher's Exact test.